New Dietary Ingredients

The dietary supplement industry continues to responsibly innovate by providing new products to support the overall health and wellness of consumers. As the industry grows,  New Dietary Ingredient Notifications are key to ensuring dietary supplement products entering the market only include legal and safe ingredients.

Browse New Dietary Ingredients Content

Orange CHPA logo on dark blue background

Press Releases and Statements

CHPA Submits Comments to FDA on NDIN Master Files for Supplements, Urges Revisions to Address Key Issues

(Washington, D.C.) – Today, the Consumer Healthcare Products Association (CHPA) released the following statement after submitting comments to the U.S. Food and Drug Administration (FDA) in response to draft guidance the Agency released in April on New Dietary Ingredient Notification (NDIN) Master Files for Dietary Supplements:

Jun 4, 2024

Several dietary supplements

Submission

Comments Regarding New Dietary Ingredients and Dietary Supplements Subject to Requirement for Pre-Market Notification

CHPA believes that FDA’s issuance of the 2022 Draft Guidance is premature. Instead, FDA’s priority should be on finalizing the 2016 Draft NDI Guidance and clarifying unanswered questions about the scope and applicability of the NDI notification requirement.

Jul 19, 2022

Infographic detailing the need for DSHEA modernization.

Infographic

Modernizing the Regulatory Framework for Dietary Supplements

An infographic outlining CHPA's priorities for the modernization of dietary supplement regulations.

Jan 12, 2022

three different kinds of dietary supplement capsules

Press Releases and Statements

CHPA Statement on Updated New Dietary Ingredient Draft Guidance in FDA’s 2022 Priorities

CHPA applauds FDA's inclusion of the publication of a revised version of the New Dietary Ingredient (NDI) Draft Guidance within its priorities for 2022.

Jul 1, 2021

Seniors reading medicine bottle labels in pharmacy

Articles

CHPA CEO Shares 2021 Industry Outlook with Chain Drug Review

For its annual year-in-review series, Chain Drug Review featured CHPA's President & CEO, Scott Melville, who offered industry insights from last year and thoughts on the outlook for 2021.

Jan 7, 2021

Child Holding Multicolored Gummy Vitamins

Press Releases and Statements

Statement by John Troup, Ph.D., CHPA Vice President of Scientific Affairs and Dietary Supplements on Los Angeles Times Column Regarding Dietary Supplement Regulations

Today’s column in the Los Angeles Times is aligned with calls from responsible manufacturers in the dietary supplement industry who agree that regulations need to be modernized and strengthened.

Dec 15, 2020

blue coronavirus particles on dark background

Press Releases and Statements

Supplement Industry Associations Applaud FDA Actions to Protect Consumers from Fraudulent Products Related to Coronavirus Disease (COVID-19)

The U.S. dietary supplement industry commends FDA for taking action to protect consumers by calling out marketers who make illegal and unsubstantiated drug claims related to COVID-19.

Apr 6, 2020

two flasks and a beaker on a table in a lab

Submission

Comments to FDA: NDI Notifications

CHPA believes that FDA’s revised 2016 Draft Guidance is an important step in helping to improve manufacturer understanding of, and compliance with, the new dietary ingredient notification requirement in Section 413 of the Federal Food, Drug, and Cosmetic Act.

Dec 12, 2016

three Dietary Supplement Powders in scoops

Submission

Comments to FDA: Premarket Notification for a New Dietary Ingredient

Echoing earlier comments submitted to the agency, CHPA and its member companies marketing dietary supplement products support the presumption of safety for dietary ingredients outlined in the 1994 passage of DSHEA.

Oct 24, 2013

Flask with Chemicals in Gloved Hand

Submission

Comments to FDA: New Dietary Ingredient Notifications and Related Issues

We take this opportunity to voice our support of comments submitted by the Council for Responsible Nutrition (CRN) regarding the appropriate interpretation of the term “chemically altered” under Section 413(a)(1) of the Federal Food, Drug, and Cosmetic Act.

Jul 12, 2013

Filter Results